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Two cDNAs which cross-hybridized with cytotoxic cell protease genes were identified in a library generated from a cyto- 
toxic T cell line. Sequence analysis revealed that the two new members of the family contained the three catalytic triad 
residues which characterize the active sites of serine proteases. A comparison of the protein sequences revealed not only 
a high degree of homology but also the conservation of some unusual structural features, These include the lack of a 
disulphide bond which spans the active site serine, the presence of a signal sequence and the inference of a dipeptide 
activation sequence. 
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1. INTRODUCTION 
Cytotoxic T lymphocytes (CTLs) bind to cells 
which bear foreign antigens and, by a mechanism 
which is not yet understood, induce them to lyse. 
Recent evidence has suggested that cytoplasmic 
granules, present in CTLs, may be primary par- 
ticipants in target cell lysis [ 11. Once physical con- 
tact is made between CTLs and the target, these 
granules fuse to the cytoplasmic membrane and 
thus deliver their contents into the intercellular 
pocket between the two cells. The target cell is 
therefore exposed to a high concentration of the 
granular proteins which set in motion a cascade of 
events ultimately leading to that cell’s demise. In- 
terestingly the CTL itself appears to be relatively 
resistant to the effects of the granular contents and 
is spared. 
Several granular proteins have been isolated in- 
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eluding perforin [2,3], proteoglycans [4] and serine 
proteases [5]. Perforin is believed to act like the C9 
component of complement and create transmem- 
brane channels in the target cell membrane, while 
the proteoglycans most likely fulfill a role in se- 
questering and inhibiting the activity of molecules 
within the granules. Evidence that serine proteases 
play a role in the lytic process is supported by the 
observations that specific inhibitors can block 
target cell lysis [6,7]. 
Our approach to study this intriguing 
mechanism has been to identify and isolate genes 
which are preferentially expressed in activated 
cytotoxic cells [8]. Two such genes which have 
been extensively characterized appear to encode 
serine proteases and we have therefore named 
them cytotoxic cell protease (CCP) 1 and -2 [9]. 
Both genes are induced upon CTL activation with 
kinetics that closely parallel the development of 
cytotoxicity [8]. Furthermore the proteins encoded 
are sequestered in the cytoplasmic granules 
discussed above [lo]. Thus we believe that CCPl 
and -2 play some role in the granule mediated 
mechanism of target cell lysis. 
From a biochemical point of view CCPl and -2 
exhibit a number of interesting features [9]. These 
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include the probable existence of zymogen forms 
by virtue of the presence of just two extra amino 
acids at the amino-termini and the lack of a 
disulphide bond which is normally involved in the 
stabilization of the substrate binding pocket. In 
addition the presence of unusual residues in 
regions involved in substrate binding have led us to 
suggest that CCPl may have an unusual substrate 
specificity [ 111. The genomic copies encoding both 
CCPl and -2 have been completely sequenced. 
Their organizations clearly indicate that the two 
are related but moreover that they belong to a new 
subfamily of serine protease genes [12]. We report 
here the cloning and sequencing of cDNAs for two 
new members of the CCP family. 
2. MATERIALS AND METHODS 
2.1. Preparation of RNA 
RNA was prepared by resuspending 2 x 10’ cells in 10 ml of 
3 M LiCI, 8 M urea and homogenizing with a polytron. The 
RNA was left in this solution to precipitate overnight, then spun 
down and resuspended in 0.1 M Tris-HCI, pH 7.5, 0.4 M LiCI. 
Poly(A)+ RNA was purified on an oligo(dT) cellulose column 
(Collaborative Research). 
2.2. cDNA library construction 
Double-stranded cDNA was synthesized from 5 pg of 
poly(A)+ RNA as described by Gubler and Hoffman [13]. The 
cDNA was methylated with EcoRl methylase (New England 
Biolabs) and then EcoRI linkers (Pharmacia) were attached. 
Size selection was carried out on a Sepharose 4B column. After 
ligation into A Zap arms (Stratagene) the cDNA was packaged 
into phage with Gigapack Plus packaging extract (Stratagene). 
2.3. Filter preparation 
After amplification of the cDNA library in E. coli BB4 
(Stratagene) 500000 pfu were plated onto 150 mm LB agar 
plates (50000 per plate) and after 17 h incubation at 37°C 
transferred onto 137 mm Hybond N nylon filters (Amersham). 
Two copies of each plate were made. After denaturation in 
0.5 M NaOH, 1.5 M NaCl and neutralization in 1 M Tris-HCI, 
pH 8, 1.5 M NaCI, the filters were baked at 80°C for 1.5 h. 
2.4. Screening with cDNA probes 
The MTL2.8.2 h Zap cDNA library was screened with cDNA 
probes which had been prepared by purifying insert DNA on a 
5% polyacrylamide gel. This purified insert DNA was labelled 
by random oligonucleotide priming. Incorporated [32P]dCTP 
was removed by passage of the sample over a Sephadex G-50 
column (Pharmacia). Specific activities were 2-5 x 10s cpm/hg 
(Cherenkov). Prior to hybridization the filters were briefly 
washed in 4 x SSC (1 x SSC is 0.15 M sodium chloride, 0.3 M 
sodium citrate, pH 7), prehybridized in hybridization buffer 
(50% formamide, 50 mM phosphate, pH 6.5, 0.1% SDS, 5 x 
Denhardts, 5 x SSC, 1 mM sodium pyrophosphate, 1OOpM 
ATP, 2.5 mM EDTA) at 42°C overnight. The hybridization 
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buffer was replaced with fresh solution which contained 
radioactive probe (1 x IO6 cpm/ml). The mixture was hybrid- 
ized for 18 h at 42°C in a shaking waterbath. The filters were 
first washed for 10 min in 2 x SSC, 0.1% SDS at room 
temperature and then for 1 h in 0.1 x SSC, 0. I % SDS at 60°C. 
Positive plaques were identified by autoradiography using 
Kodak X-Omat AR film at room temperature overnight. Agar 
plugs (0.5 cm) containing positive plaques were removed and 
soaked in SM (0.1 M NaCI, 4 M MgSO+ 20 mM Tris-HCI, pH 
7.5, 2% gelatin). Eluted phage were then screened again at a 
lower density so that positive clones were represented by single 
well isolated plaques. Agar plugs of 1.5 mm containing the 
single isolated clone were removed and soaked in SM.. 
Bluescript rescue (Stratagene) was performed to switch the 
cloned cDNAs from h Zap into the bluescript phagemid and 
transformed into E. coli XLl-blue. 
2.5. Subcloning and sequencing 
In general insert DNAs or subfragments thereof were purified 
and extracted from polyacrylamide gels after electrophoresis, 
subcloned into M13mp18 and sequenced by the dideoxy chain 
terminator method using [‘%]dATP (1400 Ci/mmol, New 
England Nuclear). Both strands of all sequences were deter- 
mined. Sequence data were analyzed using Microgenie 
(Beckman). 
3. RESULTS AND DISCUSSION 
3.1. Isolation of cDNAs which encode CCP 
family members 
A previously described cDNA library [8], con- 
structed from MTL2.8.2 [14] mRNA in pUC13, 
was hybridized with purified insert BlO and Cl 1 
[9]. A number of positive clones were identified 
and preliminary analysis indicated that they were 
identical to the probe sequences. However, one 
clone which strongly cross-hybridized with BIO 
and Cl 1 but was clearly distinguishable by restric- 
tion map analysis was found. Northern blot 
analysis (not shown) revealed that this gene 
hybridized with an mRNA of approx. 1000 
nucleotides. This is the same size of mRNA that 
BlO detects [8], however, sequence analysis reveal- 
ed that the cDNA was not BlO but a third member 
of the family. We named the cDNA D12. As D12 
did not contain the complete coding sequence we 
used it as a probe to screen a size selected cDNA 
library constructed in h Zap. A plaque with an in- 
sert of approx. 1000 base pairs corresponding to 
D12 was identified, and in addition another related 
cDNA was found (C134). 
3.2. The cDNAs 012 and CI34 appear to encode 
serine proteases 
In fig.1 the nucleotide sequences of D12 and 
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Cl34 are presented on the upper line with the 
predicted amino acids below. Both protein se- 
quences show a high degree of homology to the 
family of serine proteases and in addition contain 
the catalytic triad residues, His, Asp and Ser 
(marked by *), suggesting that they are indeed ac- 
tive serine esterases. The proteins encoded by D12 
and Cl34 have predicted molecular masses of 
27498 and 27646 Da and, in keeping with our 
original convention [9], have been named CCP3 
and -4. 
Both proteins have hydrophobic amino-termini 
which most likely act as signal peptides to direct 
the nascent proteins to the lumen of the rough en- 
doplasmic reticulum [ 151. Further evidence for this 
hypothesis comes from the occurrence of the signal 
peptidase cleavage sequence Ala-Gly-Ala [ 161 at 
the end of this stretch of residues. This would leave 
an amino-terminal sequence Glu-Glu-Ile-Ile after 
cleavage by the signal peptidase which we believe 
is activated during packaging by the removal of 
Glu-Glu. This conclusion is based in part on the se- 
quencing studies performed on the granzymes [5], 
where this class of putative serine proteases all 
started with the sequence Be-Be. Indeed a com- 
parison of these sequence data with our own 
predicted protein structures shows that, over the 
first 20 amino acid residues determined, CCP3 and 
CCP4 are identical with granzymes E and F, 
respectively. Our predicted molecular masses for 
the mature forms of CCP3 (25455 Da) and CCP4 
(25490 Da) are in close agreement with those 
demonstrated for granzymes E and F (27000 Da). 
Furthermore the extensive glycosylation seen with 
these granzymes would agree with the presence of 
4 potential N-linked glycosylation sites in the 
predicted CCP3 sequence and 3 in CCP4. This 
high degree of glycosylation together with the in- 
herent basic nature of this family of proteases (ap- 
prox. 15% basic and 7% acidic amino acids) may 
play a role in controlling their proteolytic activity. 
Within granules they may be sequestered by in- 
teraction with the acidic proteoglycans [4] and only 
become released, and therefore active, upon ex- 
ocytosis. 
3.3. CCPI-4 are homologous 
At the nucleic acid level the genes Cl 1, BlO, D12 
and Cl34 cross-hybridize even under relatively 
high stringency conditions. This indication of a 
high degree of similarity is borne out by a com- 
parison of the predicted primary amino acid se- 
quences given in table 1. Even the lowest level of 
homology is 55% (CCPl vs CCP3) and this in- 
creases up to 75% (CCP3 vs CCP4). When these 
values are compared to values of 30-40% for the 
relatedness of CCPl to serine proteases in general 
[9], it is clear that CCPl-4 belong to a closely 
related subfamily of serine proteases. This sub- 
family probably also includes cathepsin G [ 171 and 
rat mast cell protease (RMCP) II [18]. Indeed we 
have recently also shown that the genomic 
organizations of CCPl and -2 are almost identical 
with each other and with the exon-intron structure 
described for RMCP II [19]. Thus these proteins 
are likely encoded by a set of structurally 
homologous and evolutionarily closely related 
genes. 
The similarities between the CCPs is further 
highlighted in fig.2 which shows an alignment of 
the four predicted protein sequences. All four 
probably exist in a prepro-form with the signal se- 
quence comprising of the amino-terminal 18 
residues and removal of the next 2 amino acids be- 
ing required for activation. In CCP2-4 this activa- 
tion dipeptide is Glu-Glu, while for CCPl it is 
Gly-Glu. Perhaps there is some basic difference 
between the activation of CCPl versus the other 
CCPs. Cathepsin G also has the Gly-Glu sequence 
while in RMCPII it is again Glu-Glu. It is intrigu- 
ing that in the genes encoding CCPl and -2 [12] 
and RMCPII [19] there is an intron sequence 
which interrupts within this putative activation se- 
quence. 
Throughout the entire sequences these four pro- 
teins show a high degree of similarity. This is par- 
ticularly noticeable over the first 150 residues 
where large stretches of amino acids are identical 
between all four proteins. After this point CCPl 
and -2 remain similar (63%) but diverge somewhat 
from CCP3 and -4 (34-46%). This latter pair re- 
main homologous (67070), however, it should be 
noted that even these two are less similar in their 
carboxy-termini than they are over the first 150 
amino acids (8lOro). Perhaps the key to the specific 
roles played by the individual family members 
resides in their final 100 residues whereas the 
primary sequence of the first half of the molecules 
determines shared functions, targeting to granules 
for example. 
155 
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D12 
GGT CAT CCT GGG CCT GGA GCA GCA GGT GCG AGG TAG GCT GCG CCG CCC CGT CTT GTT CAT 
CCT GCT GGC CAG GGG CAG CCT CCG CAC AGC CCC GCC CCT CCT TCC TCC CCT TCC AAG GGC 
TTT GTC TCC TTT GCT CTC CTT CAA CTG AGC AGC CTT CCT GGG AAG ATG CCA CCA GTC CTG 
Met Pro Pro Val Leu 
ATT CTC CTG ACC CTA CTT CTG CCT CTT GGA GCT GGA GCA GAG GAG ATC ATC GGC GGC CAT 
Ile Leu Leu Thr Leu Leu Leu Pro Leu Gly Ala Gly Ala Glu Glu Ile Ile Gly Gly His 
GTG GTG AAG CCA CAC TCC CGC CCC TAC ATG GCG TTT GTT AAG TCT GTG GAT ATT GAA GGT 
Val Val Lys Pro His Ser Arg Pro Tyr Met Ala Phe Val Lys Ser Val Asp Ile Glu Gly 
AAT AGG AGA TAC TGT GGA GGC TTC TTG GTT CAA GAT GAC TTT GTG CTG ACT GCT GCT CAC 
Asn Arg Arg Tyr Cys Gly Gly Phe Leu Val Gln Asp Asp Phe Val Leu Thr Ala Ala 
Q 
TGC AGG AAC AGG ACA ATG ACA GTC ACA CTG GGG GCC CAC AAC ATC AAG GCT AAG GAG GAG 
Cys Arg Asn Arg Thr Met Thr Val Thr Leu Gly Ala His Asn Ile Lys Ala Lys Glu Glu 
ACA CAG CAG ATC ATC CCT GTG GCA AAA GCC ATT CCC CAT CCA GAT TAT AAT GCC ACT GCC 
Thr Gln Gln Ile Ile Pro Val Ala Lys Ala Ile Pro His Pro Asp Tyr Asn Ala Thr Ala 
TTC TTC AGT GAC ATC ATG CTG TTA AAG CTG GAG AGT AAG GCC AAG AGA ACT AAA GCT GTG 
Phe Phe Ser A 
Jf 
Ile Met Leu Leu Lys Leu Glu Ser Lys Ala Lys Arg Thr Lys Ala Val 
AGA CCC CTC AAG TTG CCC AGA CCC AAT GCC CGG GTG AAG CCA GGG GAT GTG TGC AGT GTG 
Arg Pro Leu Lys Leu Pro Arg Pro Asn Ala Arg Val Lys Pro Gly Asp Val Cys Ser Val 
GCT GGC TGG GGG TCA AGG TCC ATC AAT GAC ACT AAA GCA TCT GCC CGC CTG CGA GAG GCT 
Ala Gly Trp Gly Ser Arg Ser Ile Asn Asp Thr Lys Ala Ser Ala Arg Leu Arg Glu Ala 
CAA CTG GTC ATC CAG GAG GAT GAG GAA TGC AAA AAA CGT TTC CGA CAC TAC ACT GAG ACC 
Gln Leu Val Ile Gln Glu Asp Glu Glu Cys Lys Lys Arg Phe Arg His Tyr Thr Glu Thr 
ACA GAG ATT TGT GCT GGA GAC TTG AAG AAA ATA AAG ACT CCT TTC AAG GGT GAC TCT GGG 
Thr Glu Ile Cys Ala Gly Asp Leu Lys Lys Ile Lys Thr Pro Phe Lys Gly Asp S 
# 
Gly 
GGA CCC CTC GTG TGT GAC AAC AAA GCT TAT GGA CTT TTA GCC TAT GCA AAA AAC AGG ACA 
Gly Pro Leu Val Cys Asp Asn Lys Ala Tyr Gly Leu Leu Ala Tyr Ala Lys Asn Arg Thr 
ATC TCT TCA GGA GTC TTC ACT AAG ATT GTG CAC TTC CTG CCG TGG ATA AGC AGG AAC ATG 
Ile Ser Ser Gly Val Phe Thr Lys Ile Val His Phe Leu Pro Trp Ile Ser Arg Asn Met 
AAG CTG CTC TAA CAG TGT TAA ACC ACC CGT GCC TGA CCA GCC TGT CCG ACC TCA GGC AAG 
Lys Leu Leu 
AAC CAC GTG GAG TGG GCA GCA AAG AAT GAA AAT TCA CAA TAA ATA ACC TCC AGA CTG CAA 
Cl34 
ATG CCA CCA ATC CTG ATT CTC CTG ACC CTT CTT CTG CCT CTC AGA GCT GGA GCA GAG GAG 
Met Pro Pro Ile Leu Ile Leu Leu Thr Leu Leu Leu Pro Leu Arg Ala Gly Ala Glu Glu 
ATC ATC GGG GGC CAT GAG GTC AAG CCC CAC TCC CGC CCT TAC ATG GCA CGT GTG AGG TTT 
Ile Ile Gly Gly His Glu Val Lys Pro His Ser Arg Pro Tyr Met Ala Arg Val Arg Phe 
GTG AAA GAT AAT GGA AAA AGA CAT TCC TGT GGA GGC TTC CTG GTT CAA GAC TAC TTT GTG 
Val Lys Asp Asn Gly Lys Arg His Ser Cys Gly Gly Phe Leu Val Gln Asp Tyr Phe Val 
CTG ACG GCT GCT CAC TGC ACT GGA AGC TCA ATG AGA GTC ATA CTG GGG GCC CAC AAC ATC 
Leu Thr Ala Ala Cys Thr Gly Ser Ser Met Arg Val Ile Leu Gly Ala His Asn Ile 
156 
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AGG GCT AAG GAA GAG ACA CAG CAG ATC ATC CCT GTG GCA AAA GCC ATT CCC CAC CCA GCT 
Arg Ala Lys Glu Glu Thr Gln Gln Ile Ile Pro Val Ala Lys Ala Ile Pro His Pro Ala 
TAT GAT GAT AAG GAC AAC ACC AGT GAC ATC ATG CTA TTA AAG CTG GAG AGT AAG GCC AAG 
Tyr Asp Asp Lys Asp Asn Thr Ser 
% 
Ile Met Leu Leu Lys Leu Glu Ser Lys Ala Lys 
AGA ACT AAA GCT GTG AGG CCC CTC AAG TTG CCC AGA CCC AAT GCC CGG GTG AAG CCA GGG 
Arg Thr Lys Ala Val Arg Pro Leu Lys Leu Pro Arg Pro Asn Ala Arg Val Lys Pro Gly 
CAT GTT TGC AGT GTG GCT GGC TGG GGG AGA ACA TCC ATC AAT GCA ACA CAA AGA TCT TCC 
His Val Cys Ser Val Ala Gly Trp Gly Arg Thr Ser Ile Asn Ala Thr Gin Arg Ser Ser 
TGC CTA CGA GAG GCT CAA CTG ATC ATC CAG AAG GAT AAG GAA TGC AAA AAA TAC TTC TAT 
Cys Leu Arg Glu Ala Gin Leu Ile Ile Gin Lys Asp Lys Glu Cys Lys Lys Tyr Phe Tyr 
AAG TAT TTC AAG ACC ATG CAG ATT TGT GCT GGA GAC CCA AAG AAA ATA CAG TCT ACT TAC 
Lys Tyr Phe Lys Thr Met Gln Ile Cys Ala Gly Asp Pro Lys Lys Ile Gln Ser Thr Tyr 
AGT GGT GAC TCC GGG GGA CCC CTC GTG TGT AAC AAC AAA GCT TAT GGA GTT TTA ACC TAT 
Ser Gly Asp S r 
8 
Gly Gly Pro Leu Val Cys Asn Asn Lys Ala Tyr Gly Val Leu Thr Tyr 
GGG CTA AAC AGG ACA ATC GGT CCA GGA GTC TTC ACT AAG GTT GTG CAC TAC CTG CCG TGG 
Gly Leu Asn Arg Thr Ile Gly Pro Gly Val Phe Thr Lys Val Val His Tyr Leu Pro Trp 
ATA AGC AGG AAC ATG AAG CTG CTC TAA CAG GAG TTA AAC CAC CCG TGC CTG ACC AGC CTG 
Ile Ser Arg Asn Met Lys Leu Leu 
TCC GAC CTC AGG CAA GAA CCA TGT GGA GTG AGC AGC AAA GAA TGA AAA TTC ATA ATA AAT 
AAC CTC CAG AGT GCA AAA AAA AAA 
Fig.1. Nucleotide and inferred amino acid sequences derived from the cDNA inserts D12 and C134. 
3.4. The CCPs are structurally unusual 
In our first report of the predicted sequence for 
CCPl, we noted not only a high degree of 
homology with RMCPII but also that the two pro- 
teins shared some unusual structural features [9]. 
Both CCPl and RMCPII lacked the cysteines 
which normally form a disulphide bond between 
residues 191 and 220 in chymotrypsin. CCP2-4 
also lack this disulphide bridge. In CCPl-3 and 
RMCPII the cysteine in question before the active 
site serine is replaced with a Phe while in CCP4 
another aromatic amino acid Tyr is used. The 
Table 1 
Homologies between the predicted protein sequences for the 
four cytotoxic cell proteases 
CCPI 
CCP2 
CCP3 
CCP4 
CCPl CCP2 CCP3 CCP4 
100% 66% 55% 51% 
66% 100% 59% 59% 
55% 59% 100% 15% 
57% 59% 75% 100% 
absence of this disulphide bond could lead to an in- 
creased flexibility for the substrate binding pocket 
and thus to a potentially extended substrate 
recognition sequence. Two other primary se- 
quences, which could alter the substrate binding 
site, were also shared between CCPl and RMCPII. 
The amino acid six residues prior to the active site 
serine, which is an Asp in trypsin-like and a Ser in 
chymotrypsin-like enzymes, is an Ala in CCPl and 
RMCPII indicating a possible preference for a 
hydrophobic amino acid at the Pi position of the 
substrate. In CCP2 this residue is also an Ala while 
in CCP3 it is a Thr and in CCP4 a Ser. Thus a 
chymotrypsin-like activity is suggested for the lat- 
ter two proteases. The substitution for Ser-Trp-Gly 
216 of chymotrypsin with Ser-Tyr-Gly in CCPl 
and RMCPII is also observed with CCP2. 
However, in CCP3 and CCP4 it is changed further 
to Ala-Tyr-Ala and Thr-Tyr-Gly, respectively. 
One unusual feature of the CCPl sequence is the 
presence of an Arg residue at position 228 
(equivalent to Gly-226 in chymotrypsin) suggestive 
of an acidic substrate specificity [I 11. This 
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substitution is unique for CCPl, in CCP2 a Gln is 
found while in CCP3 and 4 a conventional Gly oc- 
curs. One intriguing specific substitution is found 
for CCP2 at position 202 (equivalent o Gly-193 in 
chymotrypsin). In the other three and indeed in all 
known serine proteases this residue is a Gly, thus 
suggesting that CCP2 may possess a most unusual 
activity. 
The overall homology of all four proteases 
leaves little doubt that they are closely related, 
however discrete differences in residues known to 
play key roles in substrate interaction suggest hat 
each has a different specificity. Possibly they play 
related but different roles in granule mediated 
cytotoxicity. 
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